309 related articles for article (PubMed ID: 28939214)
1. Biological and Molecular Characterization of Circulating Tumor Cells: A Creative Strategy for Precision Medicine?
Chen S; El-Heliebi A; Kroneis T
Adv Clin Chem; 2017; 82():71-103. PubMed ID: 28939214
[TBL] [Abstract][Full Text] [Related]
2. Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges.
Lianidou ES; Markou A
Clin Chem; 2011 Sep; 57(9):1242-55. PubMed ID: 21784769
[TBL] [Abstract][Full Text] [Related]
3. Advances in the Characterization of Circulating Tumor Cells in Metastatic Breast Cancer: Single Cell Analyses and Interactions, and Patient-Derived Models for Drug Testing.
Kujur PK; Flores BCT; Ramalingam N; Chinen LTD; Jeffrey SS
Adv Exp Med Biol; 2020; 1220():61-80. PubMed ID: 32304080
[TBL] [Abstract][Full Text] [Related]
4. Circulating Tumor Cells (CTCs) Heterogeneity in Metastatic Breast Cancer: Different Approaches for Different Needs.
Vismara M; Reduzzi C; Daidone MG; Cappelletti V
Adv Exp Med Biol; 2020; 1220():81-91. PubMed ID: 32304081
[TBL] [Abstract][Full Text] [Related]
5. Circulating tumor cells: a multifunctional biomarker.
Yap TA; Lorente D; Omlin A; Olmos D; de Bono JS
Clin Cancer Res; 2014 May; 20(10):2553-68. PubMed ID: 24831278
[TBL] [Abstract][Full Text] [Related]
6. Using CTCs for pharmacogenomic analysis.
Hart CD; Galardi F; Pestrin M; De Luca F; Risi E; Di Leo A
Pharmacol Res; 2016 Apr; 106():92-100. PubMed ID: 26921662
[TBL] [Abstract][Full Text] [Related]
7. Personalized Treatment Through Detection and Monitoring of Genetic Aberrations in Single Circulating Tumor Cells.
Tan SJ; Yeo T; Sukhatme SA; Kong SL; Lim WT; Lim CT
Adv Exp Med Biol; 2017; 994():255-273. PubMed ID: 28560679
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic cancer circulating tumor cells: applications for personalized oncology.
DiPardo BJ; Winograd P; Court CM; Tomlinson JS
Expert Rev Mol Diagn; 2018 Sep; 18(9):809-820. PubMed ID: 30099926
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumor cell as the functional aspect of liquid biopsy to understand the metastatic cascade in solid cancer.
Cortés-Hernández LE; Eslami-S Z; Alix-Panabières C
Mol Aspects Med; 2020 Apr; 72():100816. PubMed ID: 31377345
[TBL] [Abstract][Full Text] [Related]
10. Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis.
Giuliano M; Herrera S; Christiny P; Shaw C; Creighton CJ; Mitchell T; Bhat R; Zhang X; Mao S; Dobrolecki LE; Al-rawi A; Chen F; Veneziani BM; Zhang XH; Hilsenbeck SG; Contreras A; Gutierrez C; Jeselsohn RM; Rimawi MF; Osborne CK; Lewis MT; Schiff R; Trivedi MV
Breast Cancer Res; 2015 Jan; 17(1):3. PubMed ID: 25572662
[TBL] [Abstract][Full Text] [Related]
11. Molecular characteristics of circulating tumor cells resemble the liver metastasis more closely than the primary tumor in metastatic colorectal cancer.
Onstenk W; Sieuwerts AM; Mostert B; Lalmahomed Z; Bolt-de Vries JB; van Galen A; Smid M; Kraan J; Van M; de Weerd V; Ramírez-Moreno R; Biermann K; Verhoef C; Grünhagen DJ; IJzermans JN; Gratama JW; Martens JW; Foekens JA; Sleijfer S
Oncotarget; 2016 Sep; 7(37):59058-59069. PubMed ID: 27340863
[TBL] [Abstract][Full Text] [Related]
12. Circulating tumor cells in breast cancer: applications in personalized medicine.
Lee JS; Magbanua MJM; Park JW
Breast Cancer Res Treat; 2016 Dec; 160(3):411-424. PubMed ID: 27761678
[TBL] [Abstract][Full Text] [Related]
13. [Circulating tumor cells: liquid biopsy].
Alix-Panabières C; Pierga JY
Bull Cancer; 2014 Jan; 101(1):17-23. PubMed ID: 24445939
[TBL] [Abstract][Full Text] [Related]
14. Circulating tumor cells as biomarkers in head and neck cancer: recent advances and future outlook.
Tinhofer I; Staudte S
Expert Rev Mol Diagn; 2018 Oct; 18(10):897-906. PubMed ID: 30199647
[TBL] [Abstract][Full Text] [Related]
15. Molecular Profiling and Significance of Circulating Tumor Cell Based Genetic Signatures.
Kanwar N; Done SJ
Adv Exp Med Biol; 2017; 994():143-167. PubMed ID: 28560673
[TBL] [Abstract][Full Text] [Related]
16. Circulating Tumor Cells as a Tool for Assessing Tumor Heterogeneity.
Tellez-Gabriel M; Heymann MF; Heymann D
Theranostics; 2019; 9(16):4580-4594. PubMed ID: 31367241
[TBL] [Abstract][Full Text] [Related]
17. Exploring sialyl-Tn expression in microfluidic-isolated circulating tumour cells: A novel biomarker and an analytical tool for precision oncology applications.
Neves M; Azevedo R; Lima L; Oliveira MI; Peixoto A; Ferreira D; Soares J; Fernandes E; Gaiteiro C; Palmeira C; Cotton S; Mereiter S; Campos D; Afonso LP; Ribeiro R; Fraga A; Tavares A; Mansinho H; Monteiro E; Videira PA; Freitas PP; Reis CA; Santos LL; Dieguez L; Ferreira JA
N Biotechnol; 2019 Mar; 49():77-87. PubMed ID: 30273682
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumor cells: liquid biopsy of cancer.
Alix-Panabières C; Pantel K
Clin Chem; 2013 Jan; 59(1):110-8. PubMed ID: 23014601
[TBL] [Abstract][Full Text] [Related]
19. Mutational analysis of circulating tumor cells from colorectal cancer patients and correlation with primary tumor tissue.
Lyberopoulou A; Aravantinos G; Efstathopoulos EP; Nikiteas N; Bouziotis P; Isaakidou A; Papalois A; Marinos E; Gazouli M
PLoS One; 2015; 10(4):e0123902. PubMed ID: 25902072
[TBL] [Abstract][Full Text] [Related]
20. Strategies for Isolation and Molecular Profiling of Circulating Tumor Cells.
Chen JY; Chang YC
Adv Exp Med Biol; 2017; 994():43-66. PubMed ID: 28560667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
